MedTrace Logo

Effects of Royal Jelly Supplementation in Chronic Kidney Disease

NCT06438445 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2026-05-18

No results posted yet for this study

Summary

The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence in patients with chronic kidney disease (CKD) on hemodialysis (HD).

Conditions

  • Kidney Failure, Chronic
  • Oxidative Stress
  • Hemodialysis

Interventions

DIETARY_SUPPLEMENT

Real Jelly

Participants will receive 500mg of royal jelly capsules per day for two months.

DIETARY_SUPPLEMENT

Placebo

Participants will receive 500mg of placebo capsules per day for two months.

Sponsors & Collaborators

  • Universidade Federal Fluminense

    lead OTHER

Principal Investigators

  • Denise Mafra · Universidade Federal Fluminense

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-30
Primary Completion
2026-12-22
Completion
2027-04-05

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06438445 on ClinicalTrials.gov